| Health / Medical Topics |
yttrium Y 90 ibritumomab tiuxetan
Pronunciation
A drug used with the drug rituximab to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of B-cell tumors. Yttrium Y 90 ibritumomab tiuxetan contains a monoclonal antibody that binds to a protein called CD20, which is found on B cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90 ibritumomab tiuxetan is a type of radioimmunoconjugate. Also called IDEC-Y2B8, Y 90 ibritumomab tiuxetan, and Y 90 Zevalin. (NCI Dictionary)
YOU MAY ALSO LIKE
An injectable formulation of yttrium Y 90 consisting of glass microspheres containing the radioisotope yttrium Y 90. When injected into the…
A substance being studied in the treatment of certain types of B-cell cancer. Epratuzumab is a monoclonal antibody that binds to a…
A substance being studied in the treatment of some types of cancer. Yttrium Y 90 edotreotide contains a molecule that binds to…
A substance being studied in the treatment of some types of cancer. Yttrium Y 90 DOTA-tyr3-octreotide contains a molecule that binds to…
A compound that contains the radioisotope yttrium Y 90 linked to the chemical biotin. Biotin is a molecule that binds strongly to…
A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90 DOTA monoclonal antibody HuPAM4 contains a monoclonal antibody…
